Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Israel’s Zebra Medical Gets FDA Clearance for Mammography Tool
Error: Contact form not found.
by Reuters and Algemeiner Staff
A woman receiving a mammogram. Photo: Rhoda Baer / National Cancer Institute / via Wikimedia Commons.
Zebra Medical Vision, an Israeli medical imaging analytics company, said on Monday it received clearance from the US Food and Drug Administration for its mammography technology.
The company’s latest cleared product uses artificial intelligence to prioritize and identify suspicious mammograms.
The mammograms are automatically sent to Zebra’s platform, where they are processed and analyzed for suspected breast lesions. The HealthMammo product then returns its result to the radiologist.
It is the company’s first oncology tool to receive FDA clearance.
Zebra said its technology can help clear the backlog of mammograms that has resulted from the coronavirus crisis, which forced many tests to be postponed or cancelled.
